Shining a light on cancer

We are developing a multi-cancer platform powered by our Dxcover AI Engine, with first application in earlier diagnosis of brain tumours.

The Dxcover Platform has been developed to enable earlier detection of cancer.

 
Chroma-Background_02.jpg

OUR MISSION

To be a world leader in liquid biopsy and artificial intelligence for early detection  of cancers and other diseases to improve survival and quality of life.

From the Newsroom

90%

 OF PATIENTS SURVIVE WHEN CANCER IS FOUND EARLY. EARLY DIAGNOSIS BEATS CANCER.  

Reference - CRUK Statistics impact of early diagnosis

13/09/21

Dr Paul Brennan joins the Dxcover Scientific Advisory Board

Dxcover® are delighted to announce the appointment of Dr Paul Brennan to their Scientific Advisory Board (SAB). Dr Brennan is a Reader...

06/08/21

Early brain cancer detection breakthrough for Dxcover

· Blood test proves ability to identify really small brain tumours and gives hope of earlier detection and improved survival · Dxcover...

13/07/21

The future of cancer diagnostics is now

We were delighted to speak to Health Tech World recently about the future of cancer diagnostics. “Hailed as the future of cancer...